Journal of Surgical Research
Volume 140, Issue 1 , Pages 1-5 , 1 June 2007

The Devil Is in the Details: The Pharmaceutical Industry’s Use of Gifts to Physicians as Marketing Strategy

  • David W. McFadden, M.D., F.A.C.S.

      Affiliations

    • Department of Surgery, West Virginia University, Morgantown, West Virginia
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Department of Surgery, West Virginia University, #1 Medical Center Drive, Morgantown, WV 26505.
    • ,
  • Elizabeth Calvario, B.S., M.B.A.

      Affiliations

    • Graduate School of Business Administration, Waynesburg College, Waynesburg, Pennsylvania
    • ,
  • Cynthia Graves, M.D., F.A.C.S.

      Affiliations

    • Department of Surgery, West Virginia University, Morgantown, West Virginia

Received 5 October 2006

References 

  1. Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA. 2003;290:252
  2. Blumenthal D. Doctors and drug companies. N Engl J Med. 2004;351:1885
  3. Novak V. How drug companies operate on the body politic. Business Soc Rev. 1993;58;Winter
  4. Antonuccio D, Danton W, McClanahan T. Psychology in the prescription era. Am Psychol. 2003;1028;December
  5. Reist D, VandeCreek L. The pharmaceutical industry’s use of gifts and educational events to influence prescription practices: ethical dilemmas and implications for psychologists. Prof Psych Res Pract. 2004;35:329
  6. Brennan T, Rothman D, Blank L, et al. Health industry practices that create conflicts of interest. JAMA. 2006;295:429
  7. Kotler P, Keller K. Marketing Management. (12th ed).. Upper Saddle River (NJ): Pearson, Prentice, and Hall; 2006;
  8. Sierles F, Brodkey A, Cleary L, et al. Medical students’ exposure to and attitudes about drug company interactions. JAMA. 2005;294:1034
  9. Gatti J. Over half of online physicians participating in e-detailing. Direct Marketing. 2003;November 1
  10. Williams S. Food for thought: why physicians should reconsider gifts from pharmaceutical companies. Curr Surg. 2003;60:152
  11. Day M. Industry association suspends drug company for entertaining doctors. Br Med J. 2006;332:381
  12. Kaiser Family Foundation. National Survey of Physicians, Part 2. Doctors and Prescription Drugs. 2002;March
  13. Chren M. Interactions between physicians and drug company representatives. Am J Med. 1999;107:182
  14. McKinney W, Schiedermayer D, Lurie N, et al. Attitudes of internal medicine faculty and residents towards professional interaction with pharmaceutical sales representatives. JAMA. 1990;264:1693
  15. Abbasi K, Smith R. No more free lunches. Br Med J. 2003;326:1155
  16. Lexchin A, Bero L, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome. Br Med J. 2003;326:1167
  17. Chew L. A physician survey of the effects of drug sample availability on physicians’ behavior. J Gen Int Med. 1998;7:478
  18. Studdert D, Mello M, Brennan T. Financial conflicts of interest in physicians’ relationships with the pharmaceutical industry—self-regulation in the shadow of federal prosecution. N Engl J Med. 2004;351:1891
  19. Brett A, Burr W, Moloo J. Are gifts from pharmaceutical companies ethically problematic?. Arch Int Med. 2003;163:2213
  20. Wofford J, Ohl C. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes. Med Educ. 2005;5:1
  21. Moynihan R. Who pays for the pizza? (Redefining the relationships between doctors and drug companies). Br Med J. 2003;326:1193
  22. Grant D, Iserson K. Who’s buying lunch: are gifts to surgeons from industry bad for patients?. Thorac Surg Clin. 2005;15:533
  23. Wager E. How to dance with porcupines: rules and guidelines on doctor’s relations with drug companies. Br Med J. 2003;326:1196
  24. Pa. hospital bans industry gifts. AMA News. 2006;5:11
  25. Schneider J, Arora V, Kasza K, et al. Residents’ perceptions over time of pharmaceutical industry and gifts and the effect of an educational intervention. Acad Med. 2006;81:7
  26. Komesaroff P. Ethical issues in the relationships with industry: an ongoing challenge. J Paediatr Child Health. 2005;41:558
  27. Panush R. Why I no longer accept pens (or other gifts) from industry (and why you shouldn’t either). J. Rheumatol. 2004;31:1478
  28. Halperin E, Hutchison P, Barrier R. A population-based study on the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers. Int J Radiat Oncol Biol Phys. 2004;59:1477
  29. Watson P, Khandelwal A, Musial J, et al. Resident and faculty perceptions of conflict of interest in medical education. J Gen Int Med. 2005;20:357
  30. Rawlins M. Doctors and the drug makers. Lancet. 1984;2:276
  31. Kelly P. Marketing vital to health care. Advertising Age. 2004;75:28
  32. Rose R. The true colors of physicians. Med Marketing Media. 2004;3:57
  33. Chimonas S, Rothman D. New federal guidelines for physician-pharmaceutical industry relations: the politics of policy formation. Health Affairs. 2005;24:949
  34. Office of Inspector General. Compliance program guidance for pharmaceutical manufacturers. Federal Register. 2003;68:23731
  35. Romano M. Fighting graft—it’s academic. Mod Healthcare. 2006;36:8

PII: S0022-4804(06)00533-6

doi: 10.1016/j.jss.2006.10.010

Journal of Surgical Research
Volume 140, Issue 1 , Pages 1-5 , 1 June 2007

Article Tools